Paul McBarron
2020
In 2020, Paul McBarron earned a total compensation of $828.7K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary at Cyclacel Pharmaceuticals, a 53% increase compared to previous year.
Compensation breakdown
| Bonus | $105,877 |
|---|---|
| Option Awards | $436,800 |
| Salary | $268,043 |
| Other | $17,992 |
| Total | $828,712 |
McBarron received $436.8K in option awards, accounting for 53% of the total pay in 2020.
McBarron also received $105.9K in bonus, $268K in salary and $18K in other compensation.
Rankings
In 2020, Paul McBarron's compensation ranked 9,363rd out of 13,090 executives tracked by ExecPay. In other words, McBarron earned more than 28.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,363 out of 13,090 | 29th |
Division Manufacturing | 3,998 out of 5,621 | 29th |
Major group Chemicals And Allied Products | 1,626 out of 2,254 | 28th |
Industry group Drugs | 1,423 out of 1,954 | 27th |
Industry Pharmaceutical Preparations | 1,045 out of 1,459 | 28th |
Source: SEC filing on April 29, 2021.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2020.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020